Invivyd, Inc. — Director's Dealing 2022

Apr 1, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2022-03-28

Reporting Person: Elia Marc (SEE REMARKS)
Reporting Person: M28 Capital Management LP (SEE REMARKS)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.0001	6398250	Indirect

Footnotes

F1: This Form 3 is filed by M28 Capital Management LP ("M28 Capital Management") and Marc Elia ("Mr. Elia") with respect to the securities held by certain funds and accounts to which M28 Capital Management serves as investment manager. Mr. Elia is the Chief Investment Officer of M28 Capital Management and the Managing Member of M28 Capital Management GP LLC, the general partner of M28 Capital Management. The Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.